Vilintra is transforming the way clinical trials are managed through an innovative and intelligent platform tailored to meet the evolving needs of the pharmaceutical and life sciences industries.

The company addresses the complex challenges faced by pharmaceutical companies, Gx companies, clinical research organizations (CROs), and other key stakeholders in the clinical trial ecosystem. Vilintra’s platform is built to simplify, streamline, and enhance every aspect of trial management, delivering precise results in an increasingly regulated and data-intensive environment. Vilintra is also expanding its scope to support additional types of studies, including biosimilars, specialty generics, and peptides, as it pursues strategic global growth with a clear vision to become the industry’s gold standard. The platform is built around two core modules, each engineered to address critical pain points in clinical trial execution: - The Management Module integrates advanced electronic Trial Master File (eTMF) capabilities with robust features such as task management, electronic signatures, and secure document exchange. This ensures efficient oversight, seamless collaboration, and complete traceability throughout the trial lifecycle. - The Generation Module automates the creation of essential trial documents, reducing manual input by up to 40%. This module enhances consistency, accelerates timelines, and minimizes human error in documentation workflows. Vilintra is engineered to meet the highest technical and regulatory standards, ensuring full alignment with GAMP 5, GDPR, HIPAA, FDA, EMA, and ICH guidelines. The platform employs hashing technology to guarantee document integrity and immutability, providing peace of mind in an industry where compliance is paramount and quality is non-negotiable.